GAMMA Investing’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
EP
TWD
FFO
GAMMA Investing's RXST Position: Q3 2026 in Review
GAMMA Investing increased its RxSight (RXST) stake by 79% in Q3 2026, buying an estimated $663 and bringing the position to 256 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4058.
GAMMA Investing first reported a position in RXST in Q4 2023 and has held it in 12 quarters since. The position peaked at $8.51K in Q1 2025. 11 funds tracked by Wall St. Rank hold RXST as of Q3 2026.
- GAMMA Investing held 256 shares of RxSight worth $1.25K as of Q3 2026.
- GAMMA Investing bought 113 RxSight shares in Q3 2026, an estimated $663.
- RxSight made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4058 holding.
- GAMMA Investing first reported a position in RxSight in Q4 2023 and has held it in 12 quarters since.
- GAMMA Investing's RxSight position peaked at $8.51K in Q1 2025.
- 11 funds tracked by Wall St. Rank held RxSight as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.